Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non-small Cell Lung Cancer (NSCLC) With Brain Metastases”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT06501378
What this trial is testing

Cranial Radiotherapy Plus Chemoimmunotherapy in Untreated Driver-mutation Negative NSCLC With Active Brain Metastasis

Who this might be right for
NSCLC Stage IV
Fudan University 40
Testing effectiveness (Phase 2)UnknownNCT01763385
What this trial is testing

Erlotinib With Concurrent Brain Radiotherapy and Secondary Brain Radiotherapy After Recurrence With Erlotinib in NSCLC Non-increased-intracranial-pressure Symptomatic Brain Metastases

Who this might be right for
Non-small-cell Lung CancerBrain Metastases
Wu Jieping Medical Foundation 210
Testing effectiveness (Phase 2)Looking for participantsNCT05584267
What this trial is testing

Immune Treatment of Brain Metastasis of Lung Cancer Combined With Large-segmentation Precision Radiotherapy

Who this might be right for
Non Small Cell Lung Cancer
Hunan Province Tumor Hospital 140
Large-scale testing (Phase 3)UnknownNCT05104281
What this trial is testing

Osimertinib Combined With Bevacizumab in Patients With Brain Metastasis Epidermal Growth Factor Receptor (EGFR) Mutation Positive Metastatic Non-Small Cell Lung Cancer

Who this might be right for
Carcinoma, Non-Small-Cell Lung
Qingdao Central Hospital 60
Testing effectiveness (Phase 2)Ended earlyNCT05746481
What this trial is testing

Tiragolumab and Atezolizumab in Patients With Non-squamous Non-small Cell Lung Cancer (NSCLC) and Untreated Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Liza Villaruz, MD 3
Not applicableStudy completedNCT00477919
What this trial is testing

E-MOSAIC Electronic Tool to Monitor Symptoms

Who this might be right for
Cancer
Swiss Cancer Institute 264
Early research (Phase 1)Ended earlyNCT00892801
What this trial is testing

Everolimus and Whole-Brain Radiation Therapy in Treating Patients With Brain Metastasis From Non-Small Cell Lung Cancer

Who this might be right for
Lung CancerMetastatic Cancer
Vanderbilt-Ingram Cancer Center 5
Testing effectiveness (Phase 2)UnknownNCT05812534
What this trial is testing

Study of Cadonilimab Combined With Bevacizumab and Chemotherapy for Advanced Nonsquamous Non-small Cell Lung Cancer Patients With Untreated Brain Metastases

Who this might be right for
Non Small Cell Lung CancerBrain Metastases
Second Affiliated Hospital of Nanchang University 36
Not applicableNot Yet RecruitingNCT06716775
What this trial is testing

Tumor Treating Fields (TTF) in Combination with Stereotactic Radiosurgery(SRS) for Brain Metastases from Non-small Cell Lung Cancer.

Who this might be right for
NSCLC Brain Metastasis
Jiangsu Healthy Life Innovation Medical Technology Co., Ltd 200
Early research (Phase 1)Study completedNCT02228369
What this trial is testing

Oral Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitors, AZD3759 or AZD9291, in Patients Who Have Advanced Non-Small Cell Lung Cancer

Who this might be right for
EGFR Mutation Positive Advanced Non Small Cell Lung Cancer
AstraZeneca 108
Early research (Phase 1)Study completedNCT05021328
What this trial is testing

Toripalimab Combined With Anlotinib and SBRT in Patients With Untreated Brain Metastases of Driven Gene-negative NSCLC

Who this might be right for
NSCLC
Hubei Cancer Hospital 13
Not applicableUnknownNCT03414944
What this trial is testing

Elective Simultaneous Modulated Accelerated Brain Radiation Therapy for NSCLCs With Limited Brain Metastases

Who this might be right for
Brain Metastases
Shandong Cancer Hospital and Institute 30
Testing effectiveness (Phase 2)Study completedNCT04338867
What this trial is testing

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Who this might be right for
Phase II Clinical TrialNinety-six Histologically Confirmed NSCLC Patients With BMRandomized 1:1 to Received TN Plus WBR or Only WBR+1 more
Instituto Nacional de Cancerologia de Mexico 96
Testing effectiveness (Phase 2)WithdrawnNCT06676917
What this trial is testing

Datopotamab Deruxtecan (Dato-DXd) for Non-Small Cell Lung Cancer (NSCLC) Patients With Active Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
MedSIR
Large-scale testing (Phase 3)UnknownNCT03732482
What this trial is testing

Temozolomide Combine With Intensity Modulated Radiation Therapy With Simultaneous Integrated Boost for Non Small Cell Lung Cancer Brain Metastases

Who this might be right for
Non Small Cell Lung Cancer Metastatic
Taizhou Hospital 400
Testing effectiveness (Phase 2)Study completedNCT00003062
What this trial is testing

Temozolomide in Patients With Progressive or Recurrent Non-small Cell Lung Cancer

Who this might be right for
Lung Cancer
European Organisation for Research and Treatment of Cancer - EORTC 70
Testing effectiveness (Phase 2)Study completedNCT02085070
What this trial is testing

MK-3475 in Melanoma and NSCLC Patients With Brain Metastases

Who this might be right for
MelanomaNon-Small Cell Lung CancerBrain Metastases
Yale University 65
Testing effectiveness (Phase 2)Study completedNCT04824079
What this trial is testing

Keynatinib in Treated Patients With NSCLC and Brain Metastases

Who this might be right for
Non-Small Cell Lung Cancer With EGFR MutationBrain Metastases
Medolution Ltd. 16
Testing effectiveness (Phase 2)Ended earlyNCT04434560
What this trial is testing

Neoadjuvant Immunotherapy in Brain Metastases

Who this might be right for
Brain Metastases, Adult
Sarah Sammons, MD 1
Testing effectiveness (Phase 2)Study completedNCT04967417
What this trial is testing

Pembrolizumab With Standard Cytotoxic Chemotherapy in Treatment Naive NSCLC Patients With Asymptomatic Brain Metastases

Who this might be right for
Non-small Cell Lung Cancer
Samsung Medical Center 13
Next Page